Aida Pharmaceuticals, Inc.
AIDA · OTC
12/31/2007 | 12/31/2006 | 12/31/2005 | 12/31/2004 | |
|---|---|---|---|---|
| Revenue | $29,204 | $29,643 | $24,527 | $15,645 |
| % Growth | -1.5% | 20.9% | 56.8% | – |
| Cost of Goods Sold | $14,511 | $14,081 | $8,334 | $4,623 |
| Gross Profit | $14,693 | $15,562 | $16,194 | $11,023 |
| % Margin | 50.3% | 52.5% | 66% | 70.5% |
| R&D Expenses | $284 | $325 | $39 | $263 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $8,964 | $11,301 | $14,035 | $7,904 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $9,248 | $11,626 | $14,074 | $8,167 |
| Operating Income | $5,445 | $3,936 | $2,120 | $2,856 |
| % Margin | 18.6% | 13.3% | 8.6% | 18.3% |
| Other Income/Exp. Net | -$3,423 | -$1,614 | -$612 | -$321 |
| Pre-Tax Income | $2,022 | $2,323 | $1,508 | $2,535 |
| Tax Expense | $360 | $173 | $145 | $151 |
| Net Income | $2,740 | $1,454 | $1,468 | $1,635 |
| % Margin | 9.4% | 4.9% | 6% | 10.5% |
| EPS | 0.1 | 0.06 | 0.06 | 0.07 |
| % Growth | 66.7% | 0% | -14.2% | – |
| EPS Diluted | 0.1 | 0.06 | 0.06 | 0.07 |
| Weighted Avg Shares Out | 27,000 | 25,953 | 23,482 | 23,376 |
| Weighted Avg Shares Out Dil | 27,000 | 25,953 | 23,482 | 23,376 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2,022 | $1,703 | $1,103 | $481 |
| Depreciation & Amortization | $1,875 | $2,080 | $1,692 | $609 |
| EBITDA | $7,320 | $6,016 | $3,812 | $3,625 |
| % Margin | 25.1% | 20.3% | 15.5% | 23.2% |